ECZEMA ATOPIC DERMATITIS
Clinical trials for ECZEMA ATOPIC DERMATITIS explained in plain language.
Never miss a new study
Get alerted when new ECZEMA ATOPIC DERMATITIS trials appear
Sign up with your email to follow new studies for ECZEMA ATOPIC DERMATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested for severe skin rash and itch
Disease control CompletedThis study tested a new drug called camoteskimab for adults with moderate to severe eczema (atopic dermatitis). For the first 16 weeks, some participants received the drug and others received a placebo, then everyone received the drug. The main goal was to see if the drug safely …
Matched conditions: ECZEMA ATOPIC DERMATITIS
Phase: PHASE2 • Sponsor: Apollo Therapeutics Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New injection shows promise for controlling severe eczema flares
Disease control CompletedThis study tested whether an intravenous medication called EVO301 could help control moderate to severe eczema in adults. 71 participants with significant eczema covering at least 10% of their body received either the drug or a placebo. Researchers measured changes in skin severi…
Matched conditions: ECZEMA ATOPIC DERMATITIS
Phase: PHASE2 • Sponsor: Evommune, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
AI steps in to help doctors spot rare skin diseases
Diagnosis CompletedThis study tested whether an artificial intelligence (AI) tool could help doctors diagnose skin conditions more accurately, especially rare ones like generalized pustular psoriasis. Fifteen doctors reviewed 100 patient images, first giving their own diagnosis and then seeing the …
Matched conditions: ECZEMA ATOPIC DERMATITIS
Sponsor: AI Labs Group S.L • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC